The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle ...

The summit brought together global leaders to reframe advocacy as the engine of patient-centred change, proving that connected voices can drive collective impact ...

Could it be,” he asked, “that creativity needs slack and while some companies have allowed for this, others haven’t, and this is reflected in the creativity of their customer experience approaches?” I ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

Today, four out of five HCPs say they’re using LLMs to support clinical decision-making. As these LLM models solidify their ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets ...

Enterome, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has announced that the US ...